Literature DB >> 6443326

The costs and benefits of screening for PKU in Wisconsin.

H S Barden, R Kessel, V E Schuett.   

Abstract

Entities:  

Keywords:  Genetics and Reproduction; Health Care and Public Health

Mesh：

Substances：

Year:  1984        PMID： 6443326     DOI： 10.1080/19485565.1984.9988558

Source DB:  PubMed          Journal:  Soc Biol        ISSN： 0037-766X


× No keyword cloud information.
  6 in total

1.  Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Authors:  J Lord; M J Thomason; P Littlejohns; R A Chalmers; M D Bain; G M Addison; A H Wilcox; C A Seymour
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.

Authors:  C A Brosnan; P Brosnan; B L Therrell; C H Slater; J M Swint; J F Annegers; W J Riley
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

Review 3.  Food Regime for Phenylketonuria: Presenting Complications and Possible Solutions.

Authors:  Sudipt Kumar Dalei; Nidhi Adlakha
Journal:  J Multidiscip Healthc       Date:  2022-01-18

4.  Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-11-11

5.  The financial and time burden associated with phenylketonuria treatment in the United States.

Authors:  Angela M Rose; Scott D Grosse; Sandra P Garcia; Janice Bach; Mary Kleyn; Norma-Jean E Simon; Lisa A Prosser
Journal:  Mol Genet Metab Rep       Date:  2019-10-16

6.  Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness.

Authors:  Huey-Fen Chen; Angela M Rose; Susan Waisbren; Ayesha Ahmad; Lisa A Prosser
Journal:  Children (Basel)       Date:  2021-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.